IFNA1 and psoriasis: Pep3D has also been found to reduce the number of GR1+ infiltrated cells and decrease the production of IL-17A and TNF-α in the psoriatic skin of mice; thus, Pep3D has the potential to be used as a new drug for psoriasis [26], and this demonstrates IFN-α as an effective target.